Abstract
This study sought to assess the rate of hepatitis C virus (HCV) infection and associated risk factors in young adults 18–28 years of age who were incarcerated in the Rhode Island Department of Corrections. The majority of participants reported injection drug use and engaged in high-risk behaviors such as needle sharing. Despite having these risk factors and believing themselves to be at risk, the majority of youths reported no prior HCV testing. Correctional facilities present a unique opportunity to detect HCV infection and provide risk reduction education to young adults, the population with the highest rates of new infections in the US. Seventy-two incarcerated individuals with a history of drug use were approached to participate in the study; 68 completed the screening and interview. The rate of HCV infection among adults <30 years of age and incarcerated at the Rhode Island Department of Corrections in 2011 was high (24 %). In 1998, the rate of HCV among inmates <30 years of age at the same facility was only 11.4 %. These data follow the same increase in HCV infection rates among young adults observed in non-incarcerated young adults across the nation. HCV is the leading cause of liver failure and hepatocellular carcinoma in the US. Despite a decline and leveling in HCV incidence nationwide, alarming increases in HCV rates among adolescents and young adults have been reported during the period between the years 1992 and 2005. This disquieting epidemic is attributable to injection drug use amongst young adults.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003; 52(RR-1): 1–36.
Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000; 90(10): 1562–9.
Committee on the Prevention and Control of Viral Hepatitis Infections, Institute of Medicine. Hepatitis and liver cancer; a national strategy for prevention and control of hepatitis B and C. National Academies Press, 2010.
Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis. 2005; 41(7): 998–1002.
Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999; 114(1): 14–29.
Hunt DR, Saab S. Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol. 2009; 104(4): 1024–31.
De Groot AS, Stubblefield E, Bick J. Hepatitis C: a correctional-public health opportunity. Medscape Infect Dis. 2001; 3: 1–11.
Boutwell AE, Allen SA, Rich JD. Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis. 2005; 40(Suppl 5): S367–72.
Amon JJ, Garfein RS, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee SA, Hudson SM, Kerndt P, Des JD, Williams IT. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994–2004. Clin Infect Dis. 2008; 46(12): 1852–8.
Onofrey S, Church D, Kludt P, DeMaria A, Cranston K, Beckett GA, Holmberg SD, Ward JW, Holtzman D. Centers for disease control and prevention. Hepatitis C virus infection among adolescents and young adults-Massachusetts, 2002–2009. MMWR Morb Mortal Wkly Rep. 2011; 60: 537–41.
Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002; 36(3): 737–42.
Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004; 94(7): 1218–23.
Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S11–9.
De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007; 102(11): 1730–9.
Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003; 117(1): 43–8.
Kim JY, Rich JD, Zierler S, Lourie K, Vigilante K, Normandie L, Snead M, Renzi J, Bury-Maynard D, Loberti P, Richman R, Flanigan TP. Successful community follow-up and reduced recidivism in HIV positive women prisoners. J Correctional Health Care. 1997; 4: 5–16.
Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, Wohl DA, Altice FL. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010; 55(Suppl 2): S78–83.
Spaulding AC, Thomas DL. Screening for HCV infection in jails. JAMA. 2012; 307(12): 1259–60.
Acknowledgments
The authors would like to thank the RIDOC Medical Director and clinical staff. Lifespan Institution Human Subjects Institutional Review Board, The Rhode Island Correctional Institution’s Medical Review Board and OHRP approved this study. It was supported by National Institutes of Health Research Grants 1U19AI082642, 5K24DA022112, and P30-AI-42853.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McNamara, B.C., Losikoff, P.T., Huguenin, L. et al. Increasing Hepatitis C Prevalence and Associated Risk Behaviors among Incarcerated Young Adults. J Urban Health 91, 376–382 (2014). https://doi.org/10.1007/s11524-013-9807-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11524-013-9807-x